Gunter Lacey, Zhu Ji, Murphy Susan
Gunter Statistical Consulting, Provo, Utah 84604, USA.
J Biopharm Stat. 2011 Nov;21(6):1063-78. doi: 10.1080/10543406.2011.608052.
For many years, subset analysis has been a popular topic for the biostatistics and clinical trials literature. In more recent years, the discussion has focused on finding subsets of genomes which play a role in the effect of treatment, often referred to as stratified or personalized medicine. Though highly sought after, methods for detecting subsets with altering treatment effects are limited and lacking in power. In this article we discuss variable selection for qualitative interactions with the aim to discover these critical patient subsets. We propose a new technique designed specifically to find these interaction variables among a large set of variables while still controlling for the number of false discoveries. We compare this new method against standard qualitative interaction tests using simulations and give an example of its use on data from a randomized controlled trial for the treatment of depression.
多年来,亚组分析一直是生物统计学和临床试验文献中一个热门的话题。近年来,讨论的焦点集中在寻找基因组的亚组,这些亚组在治疗效果中发挥作用,通常被称为分层医学或个性化医学。尽管备受追捧,但检测具有改变治疗效果的亚组的方法有限且效力不足。在本文中,我们讨论定性交互作用的变量选择,旨在发现这些关键的患者亚组。我们提出了一种专门设计的新技术,用于在大量变量中找到这些交互作用变量,同时仍能控制错误发现的数量。我们使用模拟将这种新方法与标准的定性交互作用测试进行比较,并给出其在一项治疗抑郁症的随机对照试验数据中的应用示例。